Krishnaveni Reddy to Antiviral Agents
This is a "connection" page, showing publications Krishnaveni Reddy has written about Antiviral Agents.
Connection Strength
0,732
-
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146.
Score: 0,134
-
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med. 2015 Dec 31; 373(27):2618-28.
Score: 0,121
-
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014 Apr 17; 370(16):1483-93.
Score: 0,108
-
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014 May 15; 370(20):1879-88.
Score: 0,108
-
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med. 2014 Jan 16; 370(3):211-21.
Score: 0,106
-
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol. 2007 Apr; 102(4):880-9.
Score: 0,066
-
The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection. Transplant Proc. 2005 Dec; 37(10):4397-402.
Score: 0,060
-
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity. J Clin Gastroenterol. 2015 Apr; 49(4):336-44.
Score: 0,029